Mutations in the E2 Glycoprotein of Venezuelan Equine Encephalitis Virus Confer Heparan Sulfate Interaction, Low Morbidity, and Rapid Clearance from Blood of Mice
Open Access
- 10 October 2000
- journal article
- Published by Elsevier BV in Virology
- Vol. 276 (1), 93-103
- https://doi.org/10.1006/viro.2000.0546
Abstract
No abstract availableKeywords
This publication has 60 references indexed in Scilit:
- A Single-Site Mutant and Revertants Arising in Vivo Define Early Steps in the Pathogenesis of Venezuelan Equine Encephalitis VirusVirology, 2000
- Large-Plaque Mutants of Sindbis Virus Show Reduced Binding to Heparan Sulfate, Heightened Viremia, and Slower Clearance from the CirculationJournal of Virology, 2000
- CHEMOKINE RECEPTORS AS HIV-1 CORECEPTORS: Roles in Viral Entry, Tropism, and DiseaseAnnual Review of Immunology, 1999
- Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfateNature Medicine, 1997
- Effect of Heparin on Infection of Cells by Equine Arteritis Virus.The Journal of Veterinary Medical Science, 1997
- FACS-optimized mutants of the green fluorescent protein (GFP)Gene, 1996
- Attenuated Mutants of Venezuelan Equine Encephalitis Virus Containing Lethal Mutations in the PE2 Cleavage Signal Combined with a Second-Site Suppressor Mutation in E1Virology, 1995
- Attenuating mutations in the E2 glycoprotein gene of Venezuelan equine encephalitis virus: Construction of single and multiple mutants in a full-length cDNA cloneVirology, 1991
- Molecular modeling of protein-glycosaminoglycan interactions.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1989
- The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirusNature, 1984